Prime minister says ban would come into force next year and calls for united action across European Union Greece has announced a social media ban for under-15s from 1 January, with the country’s prime minister, Kyriakos Mitsotakis, citing rising anxiety, sleep problems and the addictive design of online platforms – although he acknowledged it may incur the wrath of some children. “We have decided ...
Prime minister says ban would come into force next year and calls for united action across European Union Greece has announced a social media ban for under-15s from 1 January, with the country’s prime minister, Kyriakos Mitsotakis, citing rising anxiety, sleep problems and the addictive design of online platforms – although he acknowledged it may incur the wrath of some children. “We have decided to go ahead with a difficult but necessary measure: ban access to social media for children under 15 years old,” he said in a TikTok video intended to address a young audience. Continue reading...
Sundry Photography Arista Networks was added as a new short idea at Hedgeye with the potential for 40% downside. "ANET is losing both dollar and port share to Nvidia and white-box vendors, a trend we expect to continue," Hedeye analyst Felix Wang wrote in a note on Wednesday. "Customer concentration further compounds risk. Microsoft, Arista’s largest customer (~26% of revenue), appears to be diver...
Sundry Photography Arista Networks was added as a new short idea at Hedgeye with the potential for 40% downside. "ANET is losing both dollar and port share to Nvidia and white-box vendors, a trend we expect to continue," Hedeye analyst Felix Wang wrote in a note on Wednesday. "Customer concentration further compounds risk. Microsoft, Arista’s largest customer (~26% of revenue), appears to be diversifying away, while we also see emerging risk with Meta. Although bulls point to Google as a stabilizing force, we do not view this as sufficient to offset broader headwinds." Wang also believes that the market is " overestimating Arista’s exposure to neocloud demand and misunderstanding Anthropic’s impact." "Finally, while Arista has historically guided conservatively, we believe consensus expectations of ~40% growth in 2026 is too high," Wang added. "Growth is likely to peak this year and decelerate into the teens by 2027–2028." Marvell Technology ( MRVL ) was also added as a long idea at Hedgeye with the potential for ~33% upside. "The Celestial AI acquisition puts MRVL firmly on the optical map, and Nvidia’s ~$2B equity investment is a major validation of both Celestial and Marvell’s broader custom XPU strategy," Wang wrote in a note on Wednesday. "We see this as a clear signal MRVL is becoming a more important player in the AI infrastructure stack." "Marvell’s role as a structural datacenter vendor is expanding, supported by strong optical module demand where its silicon is critical," Wang added. "While AVGO bulls argue inferior technology, MRVL continues to win designs." More on Arista Networks, Marvell Arista Networks: AI Networking Growth With A Durable Moat (Rating Upgrade) Marvell: Nvidia Deal Supercharges An Undervalued AI Leader Marvell's Growth Story Just Changed Arista's XPO product sees over 100 agreement partners: BNP Paribas Insider trades: Marvell Technology, Taiwan Semiconductor among notable names
YvanDube/E+ via Getty Images National Healthcare Properties Is A Company In Transition National Healthcare Properties ( NHP ) has filed to raise capital from an IPO to pay down debt, according to an S-11 registration statement and related 10-K financial statement . The REIT acquires and operates medical offices and senior housing facilities in the United States. NHP is shifting its focus to senior...
YvanDube/E+ via Getty Images National Healthcare Properties Is A Company In Transition National Healthcare Properties ( NHP ) has filed to raise capital from an IPO to pay down debt, according to an S-11 registration statement and related 10-K financial statement . The REIT acquires and operates medical offices and senior housing facilities in the United States. NHP is shifting its focus to senior housing but appears to still be in mid-transition, presenting risks for investors. What Does National Healthcare Properties Do? The company acquires and manages a diversified portfolio of senior housing operating properties and outpatient medical facilities in the U.S. As of the end of 2025, NHP owned 167 properties and a parcel of land in 29 states, comprised of 37 senior housing [SHOP] facilities and 130 outpatient medical locations [OMF], as shown on the footprint map below: SEC The firm’s total number of properties has fallen in recent years, from 202 in 2023 to 192 in 2024 and 167 in 2025. Management chooses to retain properties in markets that it believes will have ‘strong senior population growth and robust healthcare infrastructure.’ In its senior housing segment, the firm counts only three operators, as shown here: SEC Its outpatient medical segment features five major tenants plus smaller tenants in the remaining portfolio, as detailed below: SEC NHP is led by President and Chief Executive Officer Michael Anderson, who has been with the company since September 2023 and joined AR Global Investments in 2013. AR Global is the successor to AR Capital [ARC], which founded (with Nicholas Schorsch) American Realty Capital in 2006. American Realty was among other REITs founded by ARC that had various accounting, governance, and distribution issues. Investors have invested fair market value of approximately $2.5 billion as of the end of 2025. NHP is very similar to recently public Janus Living ( JAN ), in that the two firms operate their senior housing under RIDEA structu...
Architect admitted to strangling eight women, whose remains were mostly found along Long Island’s coast Rex Heuermann, a Long Island architect accused of seven murders known as the Gilgo Beach killings dating back to 1993, pleaded guilty on Wednesday – and added an eighth murder to his gruesome tally. Heuermann, who has been held in custody since he was arrested on a Manhattan street in July 2023,...
Architect admitted to strangling eight women, whose remains were mostly found along Long Island’s coast Rex Heuermann, a Long Island architect accused of seven murders known as the Gilgo Beach killings dating back to 1993, pleaded guilty on Wednesday – and added an eighth murder to his gruesome tally. Heuermann, who has been held in custody since he was arrested on a Manhattan street in July 2023, appeared in court in Riverhead, Long Island, and changed his plea to guilty in the murders of women whose remains were found years after they disappeared. Continue reading...
jetcityimage/iStock Editorial via Getty Images In the last three months since we published our recent bearish thesis on Tesla, Inc. ( TSLA ), the company’s stock has lost almost 20% of its value and underperformed against the market. Since that time, the situation for Tesla has only gotten worse. Shortly after we published that article, Tesla announced an annual decrease in revenue for the second ...
jetcityimage/iStock Editorial via Getty Images In the last three months since we published our recent bearish thesis on Tesla, Inc. ( TSLA ), the company’s stock has lost almost 20% of its value and underperformed against the market. Since that time, the situation for Tesla has only gotten worse. Shortly after we published that article, Tesla announced an annual decrease in revenue for the second year in a row. Then, at the beginning of this month, it was announced that the company’s Q1 deliveries missed expectations. As a result, we saw countless downward revisions by the analysts since there’s a risk that Tesla could once again disappoint investors and underperform in 2026. Because of that, we continue to be pessimistic about Tesla’s future and believe that a rating of Sell makes the most sense right now. It’s Not Getting Better The Q1 delivery numbers that came out earlier this month were pretty disappointing. During the quarter, Tesla delivered only 358,023 vehicles, below the expectations of around 365,000 vehicles, while it also produced 408,386 cars. This indicates that while there’s no issue with producing vehicles, the demand for them is not increasing significantly. In our previous article on Tesla, we already explained that Elon Musk’s involvement in politics last year, along with the rising competition, has negatively affected Tesla’s performance, and things are unlikely to improve anytime soon. The latest reports indicate that in Europe, Volkswagen ( VWAGY ) has now become the best-selling EV producer last year. At the same time, for thirteen months in a row, Tesla has experienced a decrease in registrations in Europe. Only in February did it see its first increase in registrations in a while, but there’s no guarantee that it will be able to retain the momentum in the following months due to the rise of competitors such as Volkswagen and BYD ( BYDDF ). Since the automotive revenues continue to generate the absolute majority of the overall sales, there’s...
jetcityimage/iStock Editorial via Getty Images In the last three months since we published our recent bearish thesis on Tesla, Inc. ( TSLA ), the company’s stock has lost almost 20% of its value and underperformed against the market. Since that time, the situation for Tesla has only gotten worse. Shortly after we published that article, Tesla announced an annual decrease in revenue for the second ...
jetcityimage/iStock Editorial via Getty Images In the last three months since we published our recent bearish thesis on Tesla, Inc. ( TSLA ), the company’s stock has lost almost 20% of its value and underperformed against the market. Since that time, the situation for Tesla has only gotten worse. Shortly after we published that article, Tesla announced an annual decrease in revenue for the second year in a row. Then, at the beginning of this month, it was announced that the company’s Q1 deliveries missed expectations. As a result, we saw countless downward revisions by the analysts since there’s a risk that Tesla could once again disappoint investors and underperform in 2026. Because of that, we continue to be pessimistic about Tesla’s future and believe that a rating of Sell makes the most sense right now. It’s Not Getting Better The Q1 delivery numbers that came out earlier this month were pretty disappointing. During the quarter, Tesla delivered only 358,023 vehicles, below the expectations of around 365,000 vehicles, while it also produced 408,386 cars. This indicates that while there’s no issue with producing vehicles, the demand for them is not increasing significantly. In our previous article on Tesla, we already explained that Elon Musk’s involvement in politics last year, along with the rising competition, has negatively affected Tesla’s performance, and things are unlikely to improve anytime soon. The latest reports indicate that in Europe, Volkswagen ( VWAGY ) has now become the best-selling EV producer last year. At the same time, for thirteen months in a row, Tesla has experienced a decrease in registrations in Europe. Only in February did it see its first increase in registrations in a while, but there’s no guarantee that it will be able to retain the momentum in the following months due to the rise of competitors such as Volkswagen and BYD ( BYDDF ). Since the automotive revenues continue to generate the absolute majority of the overall sales, there’s...
IURII KRASILNIKOV/iStock via Getty Images Pulse Biosciences, Inc. ( PLSE ) is a bioelectric medicine company working on its proprietary nPulse technology (nsPFA). This approach allows them to deliver nano pulses to clear targeted cells with a non-thermal approach. The company's priority is the advancement of the atrial fibrillation (AFib) program after obtaining strong data in a European feasibili...
IURII KRASILNIKOV/iStock via Getty Images Pulse Biosciences, Inc. ( PLSE ) is a bioelectric medicine company working on its proprietary nPulse technology (nsPFA). This approach allows them to deliver nano pulses to clear targeted cells with a non-thermal approach. The company's priority is the advancement of the atrial fibrillation (AFib) program after obtaining strong data in a European feasibility study. Another of PLSE’s programs is for treating thyroid nodules using the same nsPFA technology, which already shows promising safety and efficacy data. The company claims that its methods are differentiated by a procedural profile with advantages over alternatives that use thermal energy with weak, long-duration energy pulses. And, on balance, I feel PLSE’s technology is exciting. Unfortunately, the stock’s valuation tempers my optimism, which is why I remain neutral for now. Bioelectric Potential Pulse Biosciences, Inc. is a medical technology company that develops treatments to kill targeted cells using a nanosecond pulsed field ablation (nsPFA) system. The company was originally incorporated back in 2014 under the name of Electroblate and changed to Pulse Biosciences in 2015. PLSE is currently headquartered in Miami, Florida, with its main operating facility in Hayward, California. In my view, PLSE has very interesting bioelectric technology, which is why I felt it was worthwhile covering this name in case it goes on sale. Source: Corporate Presentation. March 2026. As a quick overview, PLSE is currently prioritizing the development of its nPulse Cardiac Catheter Ablation System . They’ve already produced positive safety and efficacy results from a European feasibility study in atrial fibrillation (AFib) executed with the participation of over 150 patients. For context, cardiac ablation is a procedure designed to treat abnormal heart rhythms like atrial fibrillation by destroying the problematic tissue that causes the arrhythmia. PLSE’s feasibility study showed 96%...
pandemin/iStock via Getty Images Investment Thesis To say that my initial recommendation for Par Pacific Holdings ( PARR ) has done well I think would be an understatement. When I first covered the stock back in mid-January the whole energy sector was in a bit of a weird spot as the US had only recently gone into Venezuela in a military operation. The whole industry thesis changed to the US now, p...
pandemin/iStock via Getty Images Investment Thesis To say that my initial recommendation for Par Pacific Holdings ( PARR ) has done well I think would be an understatement. When I first covered the stock back in mid-January the whole energy sector was in a bit of a weird spot as the US had only recently gone into Venezuela in a military operation. The whole industry thesis changed to the US now, possibly increasing its oil production even more. But since then, the conflict in the Middle East has again changed the narrative. For PARR this means a stock appreciation of 75% since my first article. I’d call that pretty successful, but again, almost entirely thanks to a change in narrative that I nor anyone else could have really predicted would happen. Since Last Coverage (Seeking Alpha) Oil prices have traded like a small cap stock the past month. As I’m writing this it seems to have declined some over 15% because of a recent ceasefire announcement by Trump. The trend I think is clear though, oil is going to continue trading at an elevated level as long as the US and Israel continue to have this increased military presence in the region, close to Iran. With PARR already being a strong refining company and more or less all operating income coming from this, increased oil prices mean a wider crack spread. For those who aren’t versed in that term, in short it means higher profits. Pre-Market Change (Seeking Alpha) I was bullish on PARR at the start of 2026, and now a little over 3 months in I am still bullish and will be reiterating my Strong Buy rating. Of course, because of the drop in oil prices, the stock price for PARR has dropped too in pre-market, making for an even better buying opportunity now in my opinion. How Lagging Canadian Feedstock Is Setting Up PARR As A Winner One of the core theses in my first article was how cheaper Canadian crude would widen the crack spread for PARR and ensure even higher profits. It was all really based on the idea that the US would...
Andrii Dodonov/iStock via Getty Images The U.S. Treasury Department will soon start a series of meetings with state insurance regulators to discuss recent developments in the private credit markets. One issue that may emerge is how private credit is rated. With the boom in private credit lending, the need to rate individual loans and securities for their risk has increased. Like public debt, firms...
Andrii Dodonov/iStock via Getty Images The U.S. Treasury Department will soon start a series of meetings with state insurance regulators to discuss recent developments in the private credit markets. One issue that may emerge is how private credit is rated. With the boom in private credit lending, the need to rate individual loans and securities for their risk has increased. Like public debt, firms offer services to rate the likelihood that borrowers will honor their obligations. They can range from large companies, like Standard & Poor's, part of S&P Global Ratings ( SPGI ), and Moody's ( MCO ), to smaller concerns, like Egan-Jones and KBRA. The Wall Street Journal highlighted concern over the potential for smaller firms to issue inflated ratings. Of particular note, the National Association of Insurance Commissioners published a study in 2024 that indicated ratings on insurers' private-credit investments were routinely inflated. But that report has since been pulled from the association's website while it clarifies its findings. The group told the newspaper that the study was based on a small sample size. Amid the increase in fears over private credit risk, the Securities and Exchange Commission last month questioned the adequacy of Egan-Jones's "financial and managerial resources to consistently produce credit ratings with integrity, particularly in light of findings from prior" annual examinations by the SEC's Office of Credit Ratings. The agency will hold hearings on whether to grant EJR's application for registration. In a request for the SEC to clarify language in its order regarding the re-registration of EJR's licenses, Egan-Jones said it's "confident the firm ultimately must prevail." The WSJ report said that state regulators' jobs were complicated by the increase of private-equity firms acquiring life and annuity insurers, which allowed insurance money to flow into private credit investments. Of ~$6T in invested assets held by life and annuity firms, almos...
Intel (NASDAQ:INTC) stock is surging 8% in Wednesday morning trading, moving from $52.91 to $57. It’s the second consecutive session of sharp gains, as the TeraFab partnership narrative pulls in buyers across retail and institutional desks. This move builds on a remarkable run. Intel stock is up 54% year-to-date. The central question for investors is ... Intel Jumps 8%: The TeraFab Excitement Is R...
Intel (NASDAQ:INTC) stock is surging 8% in Wednesday morning trading, moving from $52.91 to $57. It’s the second consecutive session of sharp gains, as the TeraFab partnership narrative pulls in buyers across retail and institutional desks. This move builds on a remarkable run. Intel stock is up 54% year-to-date. The central question for investors is ... Intel Jumps 8%: The TeraFab Excitement Is Real, but Is the Valuation Stretched?
Sky_Blue/iStock Unreleased via Getty Images CK Hutchison ( CKHUY ) ( CKHUF ) said Wednesday it has started arbitration against A.P. Moeller-Maersk ( AMKBY ) ( AMKAF ) after Panama's forced takeover of its two ports in the country. The arbitration, filed by CK Hutchison's ( CKHUY ) ( CKHUF ) Panama Ports local unit, will be heard in London and is separate from its $2B-plus damages claim against the...
Sky_Blue/iStock Unreleased via Getty Images CK Hutchison ( CKHUY ) ( CKHUF ) said Wednesday it has started arbitration against A.P. Moeller-Maersk ( AMKBY ) ( AMKAF ) after Panama's forced takeover of its two ports in the country. The arbitration, filed by CK Hutchison's ( CKHUY ) ( CKHUF ) Panama Ports local unit, will be heard in London and is separate from its $2B-plus damages claim against the Panamanian government, the company said. The move escalates a dispute that began in January, when a Panamanian court voided CK Hutchison's ( CKHUY ) ( CKHUF ) contracts to run two terminals at either end of the Panama Canal; Panama's government had awarded temporary contracts for Maersk ( AMKBY ) ( AMKAF ) subsidiaries and the Mediterranean Shipping Company to run the terminals. The dispute also complicated CK Hutchison's ( CKHUY ) ( CKHUF ) planned $23B sale of a majority stake in its global ports business to a consortium led by BlackRock and MSC; the plan, announced in March 2025, angered the Chinese government, which viewed it as bowing to U.S. pressure. More on A.P. Møller-Maersk and CK Hutchison Maersk: Upside From The Q3'25 Period With A Guidance Increase CK Hutchison: A 'Buy' On Earnings Turnaround, Portfolio Rationalization (Upgrade) CK Hutchison Holdings Q4 2025 Earnings Call Presentation